|Bid||66.80 x 800|
|Ask||66.90 x 900|
|Day's Range||66.82 - 67.23|
|52 Week Range||47.14 - 67.86|
|PE Ratio (TTM)||N/A|
|YTD Daily Total Return||4.52%|
|Beta (5Y Monthly)||0.86|
|Expense Ratio (net)||0.56%|
The two White House contenders are divided on Obamacare and Trump’s handling of the COVID-19 pandemic, but they do have some things in common on health-care matters.
Pharmaceutical exchange-traded funds (ETFs) offer investors access to a basket of U.S.-based and foreign stocks of drug manufacturers and related companies in a single investment. These companies discover, develop, and produce medications used to cure disease, vaccinate, or alleviate symptoms of illness.
Strong results led to solid trading in pharma ETFs over the past week.